SPSIP Versus RISS Block in Volume-Preserving VATS
SRVATS
Comparison of Serratus Posterior Superior Intercostal Plane Block and Rhomboid Intercostal-Subserratus Plane Block on Postoperative Analgesia and Respiratory Functions in Volume-Preserving Video-Assisted Thoracoscopic Surgery: A Prospective Randomized Controlled Trial
2 other identifiers
interventional
84
1 country
1
Brief Summary
This prospective randomized controlled study aims to compare the effects of Serratus Posterior Superior Intercostal Plane (SPSIP) block and Rhomboid Intercostal and Subserratus (RISS) block on postoperative pain, respiratory function, and recovery quality in patients undergoing volume-preserving video-assisted thoracoscopic surgery (VATS). Eighty-four patients will be randomized in a 1:1 ratio to receive either SPSIP block or RISS block. The primary outcome is the incidence of somatic pain at the chest drain insertion site at postoperative 2 hours. Secondary outcomes include pain scores, opioid consumption, quality of recovery, diaphragmatic function, pulmonary function, rescue analgesic requirements, postoperative nausea and vomiting, and block-related complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Jun 2026
Shorter than P25 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2026
CompletedFirst Submitted
Initial submission to the registry
June 12, 2026
CompletedFirst Posted
Study publicly available on registry
June 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
June 17, 2026
June 1, 2026
6 months
June 12, 2026
June 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Somatic Pain at Chest Tube Insertion Site
Incidence of somatic pain localized at the chest tube insertion site, defined as sharp localized pain aggravated by coughing or deep inspiration, recorded as present or absent.
Postoperative 2 hours
Secondary Outcomes (7)
Postoperative Pain Scores at Rest
Postoperative 2, 6, 12, and 24 hours
Postoperative Pain Scores During Movement
Postoperative 2, 6, 12, and 24 hours
Total Intravenous Morphine Consumption
Postoperative 24 hours
Interval Intravenous Morphine Consumption
Postoperative 0-8, 8-16, and 16-24 hours
Right Hemidiaphragm Excursion
Preoperative and postoperative 6 hours
- +2 more secondary outcomes
Study Arms (2)
SPSIP Block Group
EXPERIMENTALPatients will receive an ultrasound-guided Serratus Posterior Superior Intercostal Plane (SPSIP) block before induction of general anesthesia for postoperative analgesia after video-assisted thoracic surgery (VATS).
RISS Block Group
EXPERIMENTALPatients will receive an ultrasound-guided Rhomboid Intercostal and Subserratus (RISS) block before induction of general anesthesia for postoperative analgesia after video-assisted thoracic surgery (VATS).
Interventions
Ultrasound-guided Serratus Posterior Superior Intercostal Plane (SPSIP) block performed before induction of general anesthesia using local anesthetic for postoperative analgesia in patients undergoing video-assisted thoracic surgery.
Ultrasound-guided Rhomboid Intercostal and Subserratus (RISS) block performed before induction of general anesthesia using local anesthetic for postoperative analgesia in patients undergoing video-assisted thoracic surgery.
Eligibility Criteria
You may qualify if:
- Patients scheduled for elective biportal video-assisted thoracoscopic surgery (VATS) with lung parenchyma-preserving thoracic procedures under general anesthesia
- American Society of Anesthesiologists (ASA) physical status I-III
- Age between 18 and 75 years
- Provision of written informed consent
You may not qualify if:
- Use of anticoagulant or antiplatelet therapy
- Bleeding diathesis
- Known allergy to local anesthetics
- Infection at the planned block site
- Severe chronic pulmonary disease or advanced respiratory failure (e.g., severe COPD or restrictive lung disease)
- Cognitive impairment preventing reliable NRS assessment
- Pregnancy or lactation
- Chronic opioid use (regular use for ≥3 months)
- Severe hepatic or renal failure
- Refusal to participate
- Technical failure or unsuccessful regional block
- Conversion to open thoracotomy during surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ferit Yetiklead
- Bursa Sehir Hastanesicollaborator
Study Sites (1)
Bursa City Hospital
Bursa, Nilüfer, 16100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants, outcome assessors, and investigators responsible for postoperative data collection and analysis will remain blinded to group allocation throughout the study period. Block procedures will be performed by an anesthesiologist not involved in postoperative assessments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
June 12, 2026
First Posted
June 17, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
June 17, 2026
Record last verified: 2026-06